Third, chemotherapy given as part of concurrent chemoradiation may act systemically and potentially eradicate distant micrometastases.

Chemoradiation improves survival in cervical cancer patients, but benefits may decline after age 80, according to a study ...

The advent of concurrent chemoradiation has significantly contributed to the curability of head and neck cancer, including locoregionally advanced disease. Preserving organ function and reducing ...

The addition of chemoradiation did not increase grade 4 or 5 adverse events. These results were presented at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago ...

"These arms directly address whether the addition of immunotherapy to chemoradiation can improve the pCR," he said, noting that the added immunotherapy improved the pCR rate by 13 percentage points.

The authors conclude that preoperative chemoradiation does not improve survival but increases pathological response and mediastinal downstaging in patients with stage III NSCLC who undergo ...

For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was effective in the long term. Among patients with nonmetastatic, muscle-invasive ...

Data from the Phase II trial saw three of the seven patients dosed with CAN-2409 surviving for more than 35 months.

With this approval, durvalumab can now be used for treating patients with limited-stage small cell lung cancer (LS-SCLC) ...